Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Light-chain (AL) amyloidosis regimens (3 members)
- Liposarcoma medications (4 members)
- Liposarcoma medications (investigational) (1 member)
- Liposarcoma regimens (2 members)
- Liposomal chemotherapy (7 members)
- Local therapies (0 members)
- Locally delivered therapies (4 members)
- Loop diuretics (2 members)
- Low-grade glioma, pediatric medications (8 members)
- Low-grade glioma medications (12 members)
- Low-grade glioma medications (investigational) (1 member)
- Low-grade glioma regimens (3 members)
- Low-grade gliomas (5 members)
- Low-grade serous ovarian cancer medications (7 members)
- Low-grade serous ovarian cancer regimens (1 member)
- Low molecular weight heparins (5 members)
- Lung cancer regimens (2 members)
- Lung cancers (8 members)
- Lymphoma medications (11 members)
- Lymphoma regimens (6 members)
- Lymphomas (4 members)
- Lymphoproliferative disorder medications (2 members)
- Lymphoproliferative disorder regimens (3 members)
- Lymphoproliferative disorders (3 members)
- MALT lymphoma medications (19 members)
- MALT lymphoma medications (historic) (1 member)
- MALT lymphoma regimens (3 members)
- MAP2K1 inhibitors (5 members)
- MAP2K2 inhibitors (4 members)
- MAP2K4 inhibitors (1 member)
- MAP3K20 inhibitors (1 member)
- MAP4K5 inhibitors (1 member)
- MEK inhibitors (5 members)
- MET inhibitors (5 members)
- MSI-H or dMMR medications (0 members)
- MSI-H or dMMR regimens (0 members)
- MTOR inhibitors (4 members)
- Male genital cancers (7 members)
- Malignant breast neoplasm (15 members)
- Malignant gliomas (2 members)
- Malignant hematologic neoplasm (7 members)
- Malignant hematology medications (8 members)
- Malignant hematology regimens (5 members)
- Malignant neoplasm (3 members)
- Malignant peritoneal mesothelioma medications (2 members)
- Malignant peritoneal mesothelioma regimens (1 member)
- Malignant pleural mesothelioma medications (17 members)
- Malignant pleural mesothelioma regimens (1 member)
- Malignant solid neoplasm (20 members)
- Malignant solid neoplasm, BRAF-mutated medications (3 members)